The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OPTec: A phase 2 study to evaluate outpatient (OP) step-up administration of teclistamab (Tec), a BCMA-targeting bispecific antibody, in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
 
Robert M. Rifkin
Employment - McKesson
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Amgen; Celgene; Fresenius Kabi; Sandoz; Takeda
 
Henning Helmut Schade
No Relationships to Disclose
 
Gary Simmons
Speakers' Bureau - Kite, a Gilead company
 
Christopher A. Yasenchak
Stock and Other Ownership Interests - Karyopharm Therapeutics (I)
Consulting or Advisory Role - SeaGen
Speakers' Bureau - BeiGene; Lilly
Research Funding - Seagen
 
Jessica Fowler
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Thomas S. Lin
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - GlaxoSmithKline; Johnson & Johnson/Janssen
 
Brian Thomson
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Weiming Xu
Employment - Sarah Cannon Research Institute